Related Experiment Video
Updated: Jun 24, 2026
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
Published on: May 16, 2015
Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury
Christopher C Leonardo1, Keith R Pennypacker
1Department of Molecular Pharmacology and Physiology, School of Basic Biomedical Sciences, College of Medicine, University of South Florida, Tampa, FL 33612, USA. cleonard@health.usf.edu
Insights
Neonatal hypoxic-ischemic injury causes brain damage, but delayed neuroinflammation worsens it. Targeting inflammatory signals offers a promising therapeutic strategy for progressive neuropathies.
Area of Science:
- Neuroscience
- Developmental Biology
- Pathology
Background:
- Neonatal hypoxic-ischemic (HI) insults lead to significant cognitive and motor impairments.
- Current treatments targeting excitotoxicity and free radicals have shown limited clinical success.
- HI injury is increasingly recognized as a progressive process driven by delayed neuroinflammation.
Purpose of the Study:
- To review emerging concepts on the regulation of neuroinflammatory processes post-HI injury in neonatal rodent models.
- To explore the contribution of delayed neuroinflammation to the progression of neonatal HI neuropathies.
- To discuss the potential of targeting neuroinflammatory signals for delayed therapeutic interventions.
Main Methods:
- Review of rodent models investigating molecular mechanisms of HI injury.
- Analysis of cytokine, chemokine, and matrix metalloproteinase regulation following ischemia.
- Examination of evidence supporting delayed neuroinflammatory responses.
Main Results:
- Rodent models reveal progressive neuropathies following HI injury are linked to neuroinflammation.
- Cytokines, chemokines, and matrix metalloproteinases play key roles in regulating delayed inflammatory responses.
- These inflammatory mediators contribute to the progressive nature of neonatal HI brain damage.
Conclusions:
- Delayed neuroinflammation is a critical factor in the progression of neonatal HI injury.
- Targeting specific neuroinflammatory pathways offers a potential therapeutic avenue.
- Interventions targeting these pathways may be effective even when administered at clinically relevant delayed time points.
Abstract:
Exposure to hypoxic-ischemic insults during the neonatal or perinatal developmental periods produces various forms of pathology. Injuries that occur in response to these events often manifest as severe cognitive and/or motor disturbances over time. Due to difficulties regarding the early diagnosis and treatment of hypoxic-ischemic injury, there is a growing need for effective therapies that can be delivered at delayed time points. Much of the research into mechanisms of neural injury has focused on molecular targets associated with excitotoxicity and free oxygen radicals. Despite repeated success in animal models, these compounds have failed to show efficacy in clinical trials. Increasing evidence indicates that hypoxic-ischemic injury in the neonate is progressive, and the resulting neuropathies are linked to the activation of neuroinflammatory processes that occur in response to the initial wave of cell death. Understanding this latter response, therefore, will be critical in the development of novel therapies to block the progression of the injury. In this review, we summarize emerging concepts from rodent models concerning the regulation of various cytokines, chemokines, and matrix metalloproteinases in response to ischemia, and the various ways in which the delayed neuroinflammatory response may contribute to the progressive nature of neonatal hypoxic-ischemic injury in rat. Finally, we discuss data that supports the potential to target these neuroinflammatory signals at clinically relevant time points.
